BioCentury
ARTICLE | Finance

Frazier's GAIN

How GAIN Act, management teams led Frazier to back two big antibiotic A rounds

April 4, 2016 7:00 AM UTC

The benefits of the Generating Antibiotic Incentives Now Act, coupled with the ability to back repeat entrepreneurs, prompted Frazier Healthcare Partners to lead investments in two series A rounds for antibiotics companies in the span of a week.

On March 30, Zavante Therapeutics Inc. raised $45 million, including $35 million in new equity and $10 million from the conversion of outstanding convertible notes. Frazier and Longitude Capital co-led the deal, which included participation from Aisling Capital. ...